Cellectar Biosciences (CLRB) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.82
-0.65
-0.49
-0.32

Details

Expected EPS
-0.32
Actual EPS
-0.32
Surprise EPS
0
Surprise Percent
+0%

Description

Cellectar Biosciences (CLRB) has reported earnings of -0.32 per share for Q3 2024.

0 Comments

Share your thoughts